Evidence map›Paper›PMID 37441595›Full record

SynthesisTheranostics2023

A systematic review of ultrasound-mediated drug delivery to the eye and critical insights to facilitate a timely path to the clinic.

Isaac J Rad, Luke Chapman, Karnaker Reddy Tupally, Martin Veidt, Hussain Al-Sadiq, Robert Sullivan, Harendra S Parekh

Abstract readSystematic Review
In one paragraph

Synthesis in Theranostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Low-intensity ultrasound lysis of amyloid microclots in a lab-on-chip model.Frontiers in bioengineering and biotechnology · 2025
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Isaac J RadThe University of Queensland, School of Pharmacy, Brisbane, Queensland, Australia.
Luke ChapmanThe University of Queensland, Faculty of Medicine, Brisbane, Queensland, Australia.
Karnaker Reddy TupallyThe University of Queensland, School of Pharmacy, Brisbane, Queensland, Australia.
Martin VeidtThe University of Queensland, School of Mechanical and Mining Engineering, Brisbane, Queensland, Australia.
Hussain Al-SadiqAl-Asala University, Department of Industrial Engineering, Dammam, Saudi Arabia.
Robert SullivanThe University of Queensland, Queensland Brain Institute, Brisbane, Queensland, Australia.
Harendra S ParekhThe University of Queensland, School of Pharmacy, Brisbane, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultrasound has long been identified as a promising, non-invasive modality for improving ocular drug delivery across a range of indications. Yet, with 20 years of learnings behind us, clinical translation remains limited. To help address this, and in accordance with PRISMA guidelines, the various mechanisms of ultrasound-mediated ocular drug delivery have been appraised, ranging from first principles to emergent applications spanning both

Indexed as

Drug Delivery SystemsEyeAnimalsHumansReproducibility of ResultsUltrasonographyacoustofluidicsclinical translationguidelineocular drug deliveryultrasound

Identifiers

PMID37441595
PMCPMC10334839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.